Treating Critically Ill Patients Experiencing SARS-CoV-2 Severe Infection with Ig-M and Ig-A Enriched Ig-G Infusion

SARS-CoV-2 in patients who need intensive care unit (ICU) is associated with a mortality rate ranging from 10 to 40–45%, with an increase in morbidity and mortality in presence of sepsis. We hypothesized that IgM and IgA enriched immunoglobulin G may support the sepsis-related phase improving patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Corona, Alberto, Richini, Giuseppe, Simoncini, Sara, Zangrandi, Marta, Biasini, Monica, Russo, Giuseppe, Pasqua, Mauro, Santorsola, Clemente, Gregorini, Camilla, Giordano, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388937/
https://www.ncbi.nlm.nih.gov/pubmed/34438980
http://dx.doi.org/10.3390/antibiotics10080930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388937/
https://www.ncbi.nlm.nih.gov/pubmed/34438980
http://dx.doi.org/10.3390/antibiotics10080930

Ejemplares similares